Government says Corona virus in India has shown no major mutation and its vaccine will not be affected
Prime Minister concludes his tri-city tour for review of manufacture and development of the coronavirus vaccine

Health Minister says, three vaccine candidates developing well in India, with one at Stage-3 Clinical trials

Minister of Science and Technology, Dr. Harsh Vardhan chaired a meeting on COVID Appropriate Behaviour with Heads and Directors of Autonomous Institutions of Department of Science and Technology and Council of Scientific and Industrial Research yesterday. Dr Vardhan applauded the great work carried out by all scientists, even beyond their mandates,
and said that there are 9 vaccine candidates in the world which are in advanced stages. He said, in India, three vaccine candidates are developing well with one of them in the advanced Stage-3 Clinical trials and two others in stage–2 trials. He expressed the hope that India will soon have indigenous production of Corona vaccine. Pointing out that the fight against COVID is not over yet, Dr Vardhan cautioned people against complacence, carelessness and casual attitude towards combating COVID-19. He stated that the next two and half months are going to be very crucial for us in our fight against Corona because of the winter season and the festival season. He said, it becomes the responsibility of every citizen to not let our guard down and follow COVID appropriate behaviour to curb spread of the infection.

Thanks for raading “Health Minister says, three vaccine candidates developing well in India, with one at Stage-3 Clinical trials”

Read more CCEA gives approval to Rs. 3,874 crore spending on stocking low priced oil

Read more Active COVID-19 cases in country drop below 8 lakh mark for first time in one and a half months

About
Surbhi Saxena edits the daily Current Affairs News.
The author is qualified member of The Institute of Company Secretaries of India (ICSI).

3 replies on “Health Minister says, three vaccine candidates developing well in India, with one at Stage-3 Clinical trials”